Skip to content

Additional Effects of Ujjayi Pranayama

Additional Effects of Ujjayi Pranayama on Pulmonary Function in Post Coronary Artery Bypass Graft

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06663800
Enrollment
36
Registered
2024-10-29
Start date
2024-10-28
Completion date
2025-01-18
Last updated
2024-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Function, Coronary Artery Disease

Keywords

Ujjayi Paranyama, Coronary artery bypass grafting, Pulmonary Function

Brief summary

Studying the impact of Ujjayi pranayama on post-Coronary Artery Bypass Grafting (CABG) patients has the potential to positively influence healthcare. This research fosters a patient-centered approach, enhancing cardio respiratory function. Patient education on these practices can empower individuals, actively contributing to their recovery and overall well-being.

Detailed description

. Exercises such as Ujjayi pranayama lower heart rate and benefit high blood pressure sufferers. To determine additional effects of Ujjayi pranayama on pulmonary function in post coronary artery bypass Graft (CABG).

Interventions

OTHERUjjayi Paranayama

Inhale or breathe in slowly while taking a deep, prolonged breath through both nostrils. As you inhale, attempt to tighten your throat and feel the air in your throat. Air should not come into contact with the interior of the nose. When air enters the throat, an odd sound is made. Allow the breath to be loose and easy while you slightly tighten the back of your throat and hiss lightly as you breathe in and out. The sound isn't forced, but it should be loud enough for someone to hear you if they were close. Now close your right nostril and release the breath through your left. As you exhale, try making the sound HHHHHAAAA

Control Group will perform Deep Breathing Adhering to a FITT model protocol, with a frequency of 5 days. Intensity set at 8 repetitions, duration range from 10 to 15 minutes

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Participants who have 1st post op Day * Hemodynamically stable & well oriented patient * Extubated Patient * Voluntary based patients * After approval of surgeon CABG patient were recruited * Tachypnea

Exclusion criteria

* Hemodynamically unstable, * Uncontrolled Hypertension, * MSK disease, * Any previous history of tuberculosis, * Neurological disease , * Acute exacerbation of COAD & Asthma Attack, * Any trauma, anxiety or Rib fracture case , * During surgery complaint of graft failure , * Unwilling to participate , * Postural Hypotension.

Design outcomes

Primary

MeasureTime frameDescription
Borg dyspnea5days(Modified CR-10 is used to assess the degree of dyspnea, rated from 0 to 10. Zero means nothing at all, 0.5=extremely slight, 1=very slight, 2=slight, 3=moderate, 4=somewhat severe, 5=severe, 7=very severe, 9=extremely severe (almost maximal)
PFT5daysSpirometer is simple test used to help diagnose and monitor certain lung conditions by measuring how much air you can breathe out in one forced breathe. Which is a small machine attached by a cable to a mouthpiece. This spirometer yielded generally reproducible results that were generally valid compared to laboratory-based spirometry. The use of this handheld spirometer in clinical, occupational, and research settings seems justified

Secondary

MeasureTime frameDescription
Cardiac monitors5daysAfter 5, 10, 15, 20, and 30 minutes of pranayama in the study group and without pranayama in the control group, recordings of HR, SBP, DBP, RR, SpO2

Countries

Pakistan

Contacts

Primary ContactMaria Razzaq, MSCPPT
maria.razzaq@riphah.edu.pk03431597909
Backup ContactIqbal Tariq, MSCPPT
iqbal.tariq@riphah.edu.pk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026